Ovarian volume correlates strongly with the number of non-growing follicles in the human ovary by Kelsey, Tom & Wallace, W Hamish B
Hindawi Publishing Corporation
Obstetrics and Gynecology International
Volume 2012, Article ID 305025, 5 pages
doi:10.1155/2012/305025
Research Article
Ovarian Volume Correlates Strongly with the Number of
Nongrowing Follicles in the Human Ovary
Thomas W. Kelsey1 and W. Hamish B. Wallace2
1 School of Computer Science, University of St. Andrews, St. Andrews, Scotland, Kelsey KY16 9SX, UK
2 Division of Reproductive and Developmental Sciences, University of Edinburgh, Edinburgh, Scotland, Wallace EH9 1LW, UK
Correspondence should be addressed to W. Hamish B. Wallace, hamish.wallace@nhs.net
Received 5 August 2011; Revised 13 November 2011; Accepted 20 November 2011
Academic Editor: Neeta Singh
Copyright © 2012 T. W. Kelsey and W. H. B. Wallace. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
A reliable indirect measure of ovarian reserve for the individual woman remains a challenge for reproductive specialists. Using
descriptive statistics from a large-scale study of ovarian volumes, we have developed a normative model for healthy females for
ages 25 through 85. For average values, this model has a strong and positive correlation (r = 0.89) with our recent model of
nongrowing follicles (NGFs) in the human ovary for ages 25 through 51. When both models are log-adjusted, the correlation
increases to r = 0.99, over the full range of ovarian volume. Furthermore we can deduce that an ovary of 3 cm3 volume (or
less) contains approximately 1000NGF (or fewer). These strong correlations indicate that ovarian volume is a useful factor in the
indirect estimation of human ovarian reserve for the individual woman.
1. Introduction
The human ovary contains a fixed pool of nongrowing folli-
cles (NGFs) maximal at 18–22 weeks gestation that declines
towardsmenopause when fewer than one thousandNGFs are
present [1]. The age at menopause in western populations is
50-51 years on average [2, 3]. Recent socioeconomic changes
have resulted in an increasing number of women delaying
childbirth until later in life, when their fertility is significantly
compromised compared to younger women. This has created
significant pressure on fertility services and an increased
demand for assisted conception treatments (ACTs).
The assessment of ovarian reserve for the individual
woman remains problematic. Direct estimation of the num-
ber of NGFs remaining in an individual ovary is currently
impossible in vivo. A number of physical and humoral factors
have been investigated in isolation and in combination. The
measurement of follicular stimulating hormone (FSH) in the
early follicular phase of the menstrual cycle is an accurate
indicator of ovarian function but is not a good predictor
of time remaining to menopause [4]. More recently, anti-
Mullerian hormone (AMH) has shown promise as a measure
of ovarian reserve [5, 6], and transvaginal ultrasound estima-
tion of antral follicle counts (AFCs) is both a useful indicator
of ovarian function and reserve [7]. The role of ovarian vol-
ume in the assessment of ovarian reserve remains uncertain,
with some studies suggesting that a reduced volume is a good
predictor of poor outcome for assisted conception [8, 9].
Ovarian volumes increase exponentially from birth to
pubertal ages and are believed to be at a maximum shortly
after puberty [10, 11]. Many studies have been published
using ovarian volumes taken from women either attending
infertility clinics or having polycystic ovarian syndrome; Lass
and Brinsden have published a detailed survey of these [12].
There have been few studies on the ovarian volumes of
groups of women who approximate the healthy population.
Most of these were small-scale studies, with exemplars taking
measurements from 38 [13] and 377 [14] subjects. One
study dominates in terms of size and scope. Pavlik et al.
recorded 58,673 volumes from 13,963 subjects taking part
in an ovarian cancer-screening project [15]. Each ovary was
measured in three dimensions via transvaginal ultrasound.
Volumes were calculated using the formula for a prolate
ellipsoid: L × H × W × 0.523. We consider this study to
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Table 1: Curve-fitting results for 10 constructed datasets.
Dataset
Highest-ranked sigmoidal model Highest-ranked model
Height Centre Width r2 Parameters r2
1 1.07 47.1 −13.7 0.667 13 0.678
2 1.07 47.0 −13.6 0.671 12 0.681
3 1.08 46.9 −13.7 0.669 12 0.679
4 1.07 47.0 −13.6 0.669 13 0.680
5 1.07 47.1 −13.6 0.672 13 0.682
6 1.08 46.9 −13.7 0.669 12 0.683
7 1.08 46.8 −13.6 0.669 12 0.680
8 1.07 47.0 −13.7 0.672 12 0.682
9 1.07 46.9 −13.7 0.668 13 0.678
10 1.07 47.0 −13.7 0.668 12 0.678
be the most comprehensive and therefore use it as our sole
reference for ovarian volumes.
The aim of this paper is to correlate ovarian volumes
as measured by transvaginal ultrasound with our recent
description of the decline of the NGF population in the
human ovary. Lass and Brinsden have shown that women
with small ovaries (less than 3mL) had a more than 50%
risk of abandonment of IVF cycle before NGF retrieval, and
that those who did not abandon required more aggressive
stimulation than normal [12]. A close, positive correlation
between volumes and NGF counts would provide further
evidence that women with small ovaries (irrespective of age)
are less likely to respond well to ACT.
2. Materials and Methods
Summary statistics were extracted from the Pavlik et al. study
[15]: for each year of age from 25 through 85 we obtained the
mean ovarian volume, the upper standard deviation, and the
number of observations. The total number of observations
was 58,255. We derived the log-normal mean and standard
deviation for each year of age using standard equations.
Parametric bootstrapping is a standard statistical technique
for simulating datapoints from a known distribution [16].
The R statistical package (The R Foundation for Statistical
Computing, Vienna, Austria) has a parametric bootstrap-
ping function that returns a fixed number of randomdeviates
from given log-normal means and standard deviations. We
used this function to create 10 datasets each having the same
descriptive statistics as the Pavlik et al. study (so that each
dataset reproduces their published results).
For ages 25–85, inspection of the Pavlik et al. plots
shows that ovarian volumes appear to progress from high
values declining to a minimum with increasing age. We
therefore fitted seven sigmoidal (or “S-shaped”) models
to the datasets using TableCurve2D (Systat Software Inc.,
Chicago, IL, USA) and ranked the returned models by the
r2 coeﬃcient of determination. We also fitted 3,164 arbitrary
and biologically nonplausible models to the same datasets in
order to determine the maximum r2 obtainable for that data.
We produced a normative model of ovarian volumes
from the highest-ranked sigmoidal models and calculated the
correlation coeﬃcient, r, for mean ovarian volume against
mean NGF population as given by the Wallace-Kelsey model
[1] for ages 25 through 51 (since the highest age used in the
derivation of the NGFmodel was 51 years, and the lowest age
in the Pavlik et al. study was 25 years). For this correlation,
neither quantity was log-adjusted. Variability increases with
both ovarian volume and NGF population; hence both
quantities are log-normally distributed. Therefore, in order
to test correlation between predictive intervals as well as
mean values, we log-adjusted both models and calculated
correlation coeﬃcients for mean values and upper and lower
95% prediction intervals (mean plus or minus 1.94 standard
deviations) for the models.
3. Results
The curve fitting results are shown in Table 1. For each
dataset a similar sigmoidal model gave the best fit. The
r2 coeﬃcients of determination were typically 1% below
the highest r2 obtained for any model, indicating that our
biologically plausible choice of sigmoidal model does not
lead to significant under-fitting for these data.
Since there were no large-scale variations for any of the
datasets, we report a three-parameter cumulative Lorentzian
normative model of ovarian volume given by
log10(ovarian volume) =
a
π
(
arctan
(
age− b
c
)
+
π
2
)
(1)
with height parameter a = 1.08 (95% CI 1.02 through 1.13),
centre parameter b = 46.9 (95% CI 45.4 through 48.3),
and width parameter c = −13.7 (95% CI −14.6 through
−12.9). This model can be interpreted as rapid decline in
human ovarian volume from about age 33 to about age 61,
with the rate of decline slowing after about age 47. A log-
unadjusted version of the model is given in Figure 1, together
with intervals in which the ovarian volumes of 68% and 95%
of the population are expected to fall (mean plus or minus
one or two standard deviations, resp.).
The correlation of mean ovarian volumes against mean
NGF population, for ages 25 through 51, is given in Figure 2.
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Figure 1: A normative model for the decline in human ovarian
volumes from age 25. The centre line is the mean expected value for
a given age. 68% of human ovarian volumes calculated at a known
age are expected to fall within the lines at 1SD either side of the
mean; 95% are expected to fall within the outer lines at 2SD from
the mean.
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Figure 2: A strong and positive correlation, r = 0.89, between
log-unadjusted mean ovarian volumes and mean NGF populations
given by the Wallace-Kelsey model [1].
We report a strong and positive correlation, r = 0.89,
for this age range. For log-adjusted values of both ovarian
volumes and NGF populations, we report extremely strong
and positive correlations, r = 0.99, both for mean values
and for decile, quartile, and percentual prediction limits.
Figure 3 illustrates this for mean values and 95% prediction
limits. Using this correlation over all ranges of variation from
average, we can infer that a population of 1000 NGFs (i.e.,
103) at any age represents approximately 3 cm3 volume (i.e.,
100.48).
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Figure 3: Extremely strong and positive correlations, r = 0.99
for each pair of lines, between log-adjusted ovarian volumes and
the Wallace-Kelsey model of NGF population [1]. The inner lines
are mean values; the outer lines are 95% prediction limits for
the respective values. An NGF population of 1,000 (i.e., 103)
corresponds to an ovarian volume of 3.01 cm3 (i.e., 100.48).
4. Discussion
We have shown that there is a strong and positive correlation
between ovarian volume and NGF population in the human
ovary. We can therefore hypothesise that small ovaries have
reduced numbers of NGFs and furthermore can calculate the
number of NGFs in an ovary of known volume. We have also
shown that an NGF population of one thousand corresponds
to an ovarian volume of 3.01 cm3.
Our results provide a simple method for assessment of
remaining NGF pool for an individual. First obtain an accu-
rate measurement of ovarian volume (by taking the average
of two or more transvaginal ultrasoundmeasurements, as set
out in [17]). Use the base-10 logarithm of this value and the
age of the individual to enter a datapoint on Figure 3. Read
the value for this datapoint from the secondary y-axis, and
raise 10 to a power of this value. The resulting number is an
estimate of the number of NGFs remaining in that ovary.
Previous studies have shown that for women over
34 years of age, ovarian volume correlates strongly with
follicular density in cortical tissue [9], and that large ovarian
volumes are associated with good assisted reproductive
technology outcomes whereas small ovarian volumes are
associated with poor outcomes [8]. Our results agree with
both sets of findings and also provide the quantitative
information needed to say what “large” and “small” ovaries
mean for the healthy population. Large (resp., small) ovaries
at a known age have volumes greater (resp., less) than 1 SD
from the average; very large and small ovaries are more than
2 SD away from average (Figure 1). This study extends and
improves a similar study by Wallace and Kelsey [18] that
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reported a strong correlation between an earlier model of
NGF decline with age and the mean ovarian volumes given
by Pavlik et al. In this paper we have used an improved NGF
model and have correlated not only average values but also
all variations in both ovarian volume and NGF population.
Since data of this size and distribution provide similar
goodness-of-fit results for the models tested (Table 1), and
since each of our datasets provides the same results as the
original paper, we have made the important assumption that
the ten generated datasets accurately represent the original
dataset [15].
We acknowledge a number of specific study limitations,
the most important of which is that no causal link has
been shown that explains the high correlation coeﬃcients
obtained in this study: it may be the case that a large ovary
contains a large number of NGFs (in general) as our results
suggest, but there is no direct evidence for this. Bowen et
al. [19] have shown that reduced ovarian volumes predict
reduced ovarian reserve (in terms of increased FSH) for
infertile women, but we know that there are no studies that
translate this finding to the fertile (normal) population.
A further limitation is that our ovarian volumemodel has
not been validated: we have not tested how well or poorly
the model generalises to unseen data. Indirect evidence for
the validity of our model is given by Holm et al. [20].
This study produced a normative model of ovarian volumes
for ages ranging from birth to 26 years, with a predicted
average volume at age 24 of 7.8mL. This entirely separate
calculation agrees exactly with ours: we also predict an
average volume of 7.8mL at 24 years of age. Our model also
agrees in qualitative terms (i.e., curvilinear decline at ages
of menopause, followed by linear decline at older ages) with
the normative model for postmenopausal ovarian volumes
produced by Tepper et al. [21]. Our model reports smaller
means and ranges than this study, due either to systematic
diﬀerences in volume calculation between the two research
groups or to the much smaller sample size (n = 311) for
Tepper et al.
5. Conclusions
We have presented a normative model for human ovarian
reserve for ages 25 through 85 and demonstrated that about
two thirds of the variation in ovarian volumes for this age
range is due to age alone. If our model were to be externally
validated, and if it were shown that (in general) larger
ovaries contain more NGFs than smaller ones (possibly by
inference from a mammalian model), then the strong and
positive correlations that we have reported indicate that the
remaining follicle pool for individuals can be accurately
assessed using ovarian volumes as a surrogate measure.
Moreover, our model can be correlated against other models
of indirect measures of ovarian reserve, such as the normative
model for serum AMH in the healthy population [22, 23].
We speculate that a multivariate model can be derived,
involving both endocrine factors and physiological factors
(such as ovarian volume and antral follicle count), that will
allow the accurate estimation of remaining fertile lifespan
for individual women. This would have major implications
for the planning of assisted conception cycles and for the
preservation of fertility for survivors of cancer earlier in life.
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